SLNO position history
The shares of Soleno Therapeutics (SLNO) that Khrom Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q1: 1,511,481 shares, $51M, 4.6% of portfolio, New
- 2026 Q2: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|